Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

1(25%)

Results Posted

50%(1 trials)

Terminated

1(25%)

Phase Distribution

Ph not_applicable

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution1 total trials

N/ANon-phased studies

1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(2)

Terminated(1)

Detailed Status

Completed2

Recruiting1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

recruiting125%

terminated125%

completed250%

Recent Activity

1 active trials

Showing 4 of 4

recruiting

Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies

NCT04888338

terminated

Contemporary Characteristics of Penile Cancer

NCT04996849

completednot_applicable

Effects of Filter Ventilation and Ventilation Information on Product Use Behaviors in Cigarette Smokers

NCT04744285

completed

Utilizing Smart Devices to Identify New Phenotypical Characteristics in Movement Disorders

NCT03638479

Clinical Trials (4)

Showing 4 of 4 trials

NCT04888338

Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies

Recruiting

NCT04996849

Contemporary Characteristics of Penile Cancer

Terminated

NCT04744285Not Applicable

Effects of Filter Ventilation and Ventilation Information on Product Use Behaviors in Cigarette Smokers

Completed

NCT03638479

Utilizing Smart Devices to Identify New Phenotypical Characteristics in Movement Disorders

Completed

All 4 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 4